Uncategorized
Waltham, MA, March 10,
2020 — Trinity Life Sciences,
a leader in global life sciences solutions, is launching an ongoing advisory
program that will monitor the effects of the novel coronavirus on
biopharmaceutical companies operations. The advisory is based on the feedback
from surveyed pharmaceutical companies in the TGaS network, a division of
Trinity.
Some of the immediate results show that 100 percent of biopharmaceutical
companies participating in the survey say they have travel restrictions in
place. Eleven out of…
Read Now
Waltham, MA, March 10,
2020 — Trinity Life Sciences,
a leader in global life sciences solutions, is launching an ongoing advisory
program that will monitor the effects of the novel coronavirus on
biopharmaceutical companies operations. The advisory is based on the feedback
from surveyed pharmaceutical companies in the TGaS network, a division of
Trinity.
Some of the immediate results show that 100 percent of biopharmaceutical
companies participating in the survey say they have travel restrictions in
place. Eleven out of…
Read Now
Uncategorized
Waltham, MA., March 9,
2020 — Trinity Life Sciences,
a leader in global life sciences solutions, announces the availability of the
first and only end-to-end market access consulting solution for
biopharmaceutical companies. The new offering includes expertise on market
access, pricing and contracting along with the best-in-class organizational
approaches needed to successfully commercialize biopharmaceutical products.
“As public pressure for pricing transparency for therapies
that extend and save lives increases, the need for an integrated, seamless
solution that demonstrates the differentiated…
Read Now
Waltham, MA., March 9,
2020 — Trinity Life Sciences,
a leader in global life sciences solutions, announces the availability of the
first and only end-to-end market access consulting solution for
biopharmaceutical companies. The new offering includes expertise on market
access, pricing and contracting along with the best-in-class organizational
approaches needed to successfully commercialize biopharmaceutical products.
“As public pressure for pricing transparency for therapies
that extend and save lives increases, the need for an integrated, seamless
solution that demonstrates the differentiated…
Read Now
Waltham, MA, March 2,
2020 – Trinity Life Sciences, a global leader in life sciences solutions,
today announced it continues to see inflective growth in its Health
Economics and Outcomes Research (HEOR) services.
HEOR, one of the fastest-growing functions in the
pharmaceutical industry, provides value-based insight to pharmaceutical
companies and assists healthcare payers in determining if treatments are
effective in the populations they serve.
“HEOR plays a central role in the internal decision-making
of a pharmaceutical or biotech company,” said…
Read Now
Uncategorized
Waltham, Mass., February
24, 2020 — Trinity Life
Sciences, a global life sciences commercialization solutions provider with
extensive experience in launch planning, is sharing lessons learned in its
latest report, “Achieving
Launch Excellence in this New Decade: Four Must-Haves for an Agile Launch
Strategy.”
Life sciences companies preparing to launch a product often
find themselves working from patchwork plans with little cross-functional
alignment. This report was developed to guide Chief Commercial Officers (CCOs) in
focused launch planning across all areas…
Read Now
Waltham, Mass., February
24, 2020 — Trinity Life
Sciences, a global life sciences commercialization solutions provider with
extensive experience in launch planning, is sharing lessons learned in its
latest report, “Achieving
Launch Excellence in this New Decade: Four Must-Haves for an Agile Launch
Strategy.”
Life sciences companies preparing to launch a product often
find themselves working from patchwork plans with little cross-functional
alignment. This report was developed to guide Chief Commercial Officers (CCOs) in
focused launch planning across all areas…
Read Now
WALTHAM, Mass. — TRINITY, the global life sciences commercialization solutions provider, today announced it has acquired Bell Canyon Consulting to create a new combined offering that will address critical gaps in the market for improved data management and reporting. With the Bell Canyon acquisition, TRINITY will be able to provide both technical knowledge and subject matter expertise, improving data transparency, quality and access. The integration with Bell Canyon will advance TRINITY’s vision of providing evidence-based solutions and enhance TRINITY’S existing…
Read Now
Today TRINITY published a white paper exploring the truth of reimbursement challenges for cell and gene therapies (CGTs). In recent years, we have seen cell and gene therapies (CGTs) morph from a small niche into one of the most exciting markets in biopharma. We are fast approaching an inflection point when many CGTs will gain approval and offer clinical benefits for areas of high unmet need. This development is positive for patients with rare diseases, and the insurance market will…
Read Now
WALTHAM, Mass. — Trinity Partners, a strategic partner to leading life sciences companies, today announced it has changed its brand identity to TRINITY and launched its new website at trinitylifesciences.com. The 20-year-old firm provides a range of integrated, evidence-based solutions specifically designed and deployed to solve critical commercialization challenges. TRINITY has grown to over 250 professionals, working with over 100 clients annually, including 18 of the top 25 global biopharma manufacturers and dozens of leading medical device and diagnostic companies.…
Read Now
